Factor Xiiia

Download PDF

Recent Publications on Factor Xiiia:
Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model. Diabetic subjects have been shown to have altered fibrin network...	28th June, 2008	School of Physiology, Nutrition and Consumer Science, Department	Thromb Haemost. 2008 Apr;99(4):691-700.
Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit. The first step in the activation of plasma factor XIII (FXIII) is the...	28th June, 2008	University of Debrecen, Medical and Health Science Center, Clinical	Thromb Haemost. 2008 Apr;99(4):668-74.
Immunohistochemical clues at aging of the skin microvascular unit. Background: Skin aging is a multifaceted process influenced by various...	20th June, 2008	Department of Dermatopathology, University Hospital Sart Tilman, Liege,	J Cutan Pathol. 2008 Jun 17;. DOI Direct Link
Polyphosphate enhances fibrin clot structure. Polyphosphate, a linear polymer of inorganic phosphate, is present in...	12th June, 2008	Department of Medicine, College of Medicine, University of Illinois at	Blood. 2008 Jun 10;. DOI Direct Link
Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. Two transglutaminases (TGs), factor XIIIA (FXIIIA) and TG2, undergo...	12th June, 2008	Veterans Affairs Medical Center, UCSD, La Jolla, CA 92161, USA.	J Cell Sci. 2008 Jul 1;121(Pt 13):2256-64. Epub 2008 Jun 10. DOI Direct Link
→View more research publications.

BioNews Results for Factor Xiiia:
New England Journal of Medicine and the Lancet Publish Results from Landmark Rivaroxaban Studies	Pharma Live:  Jun 28 2008 5:19AM Matching: factor
VIA Pharmaceuticals Set to Join Russell Microcap Index	DiGiTAL50:  Jun 28 2008 6:42AM Matching: factor
Mate choice in plants	Genetic Engineering News:  Jun 28 2008 4:53AM Matching: factor
High Growth Reported for the World Blood Banking & Blood Products Market	Market Wire:  Jun 27 2008 9:50PM Matching: factor
Biovail Comments on Eugene Melnyk's Continued Distortion of the Facts	SmartBrief:  Jun 27 2008 5:47AM Matching: factor
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Factor Xiiia Patents:
US Patent No.	Title
7112317	Combined methods and compositions for tumor vasculature targeting and tumor treatment
7186803	Human vanilloid receptor VR3 protein
7189410	Supplemented and unsupplemented tissue sealants, methods of their production and use
7189829	Baboon TAFI polypeptides
7196054	Methods for treating wound tissue and forming a supplemented fibrin matrix
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Factor Xiiia scientists - we have details of around 102 individuals working on Factor Xiiia .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.